文献速递临床试验与 GCP

胺碘酮与艾司洛尔预防心脏瓣膜或主动脉手术再灌注心室颤动比较:随机对照临床试验研究方案

Comparison of amiodarone and esmolol for prevention of reperfusion ventricular fibrillation in individuals undergoing heart valve or aortic surgery: a study protocol for a randomized controlled clinical trial.
PubMed 文献 · Trials · 2023-11-27

这是一项单中心、前瞻性、双盲、对照临床试验方案,计划纳入260例心脏瓣膜或主动脉手术患者,随机分为预防性艾司洛尔组(干预组)或胺碘酮组(对照组),主要结局为体外循环主动脉开放后再灌注心室颤动的发生率。

要点

  • 计划纳入260例心脏瓣膜或主动脉手术患者,随机分为艾司洛尔组与胺碘酮组。
  • 主要结局为体外循环主动脉开放后再灌注心室颤动的发生率。
  • 次要结局包括心脏自动复苏率、电除颤能量与频率、电除颤次数及起搏器使用情况。

核心结论

  • 该研究将确定预防性艾司洛尔是否比胺碘酮更有效地降低心脏瓣膜或主动脉手术患者再灌注心室颤动的发生率。

研究设计与样本

  • 单中心、前瞻性、双盲、对照临床试验,计划纳入260例接受心脏瓣膜或主动脉手术的患者。
  • 患者随机分配至预防性艾司洛尔治疗(干预组)或胺碘酮治疗(对照组)。

主要发现

  • 原文未报告结果,本研究为研究方案。

关键数值与推荐

  • 主要结局为体外循环主动脉开放后再灌注心室颤动的发生率。
  • 次要结局为两组心脏自动复苏率、电除颤能量与频率、电除颤次数及起搏器使用情况。
  • 记录患者一般情况及麻醉时长、体外循环时长、主动脉阻断时长和手术时间。
  • 比较两组在麻醉诱导(T1)、手术开始(T2)、体外循环开始(T3)、主动脉阻断(T4)、主动脉开放(T5)、开放后10分钟(T6)、20分钟(T7)、30分钟(T8)、体外循环停止(T9)及手术结束(T10)时的心率、平均动脉压和中心静脉压。
  • 比较T1、T5、T9和T10时的血气分析结果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amiodarone and esmolol can help to prevent and treat post-cardiac surgery reperfusion ventricular fibrillation. However, the relative efficacies of these two drugs remain unknown. The aim of the current trial is to compare the performances of amiodarone and esmolol for preventing reperfusion ventricular fibrillation following open heart surgery. METHODS/DESIGN: This is a single-center, prospective, double-blind, controlled clinical trial. A total of 260 patients undergoing heart valve or aortic surgery will be assigned randomly to treatment with prophylactic esmolol (intervention group) or amiodarone (control group). The main outcome is the incidence of reperfusion ventricular fibrillation following aortic opening during extracorporeal circulation. The secondary outcomes are the rate of automatic cardiac resuscitation, energy and frequency of electrical defibrillation, number of electrical defibrillations, and pacemaker use in the two groups of patients. Information on the patients' general condition and the durations of anesthesia, extracorporeal circulation, aortic occlusion, and operation time will be recorded. We will also compare the heart rate, mean arterial pressure, and central venous pressure between the two groups of patients at induction of anesthesia (T1), start of surgery (T2), start of extracorporeal circulation (T3), aortic block (T4), aortic opening (T5), after opening for 10 (T6), 20 (T7), and 30 min (T8), at cessation of extracorporeal circulation (T9), and at the end of surgery (T10) and compare blood gas analysis results at T1, T5, T9, and T10. DISCUSSION: This study will determine if prophylactic esmolol is more effective than amiodarone for reducing the incidence of reperfusion ventricular fibrillation in patients undergoing heart valve or aortic surgery. TRIAL REGISTRATION: China Clinical Trials Registry ChiCTR1900026429. Registered on 2019.10.9.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhu D, Li Y, Tian AY, et al. Comparison of amiodarone and esmolol for prevention of reperfusion ventricular fibrillation in individuals undergoing heart valve or aortic surgery: a study protocol for a randomized controlled clinical trial. Trials. 2023. PMID: 38012733. doi:10.1186/s13063-023-07816-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。